Showing 371-380 of 5598 results for "".
Navigating the LGMD2I/R9 Diagnostic Pathway
https://reachmd.com/programs/cme/navigating-the-lgmd2ir9-diagnostic-pathway/35879/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Navigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
https://reachmd.com/programs/clinicians-roundtable/navigating-pediatric-obesity-tools-and-strategies-for-success-in-primary-care/37868/Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it’s also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that supporSchizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
https://reachmd.com/programs/neurofrontiers/schizophrenia-and-heart-health-navigating-the-hidden-risk-of-sudden-cardiac-death/27075/Learn about strategies to improve both mental and heart health in schizophrenia patients to reduce the risk of sudden cardiac death.Navigating the Ongoing Threat of COVID-19: Recommendations for Older Adults
https://reachmd.com/programs/clinicians-roundtable/navigating-the-ongoing-threat-of-covid-19-recommendations-for-older-adults/29090/Dive into the latest research and recommendations on COVID-19 in older adults.When Parents Become National Health Advocacy Leaders: Gene Kestenbaum and the Crohn's and Colitis Foundation
https://reachmd.com/programs/villanova_health_summit/when-parents-become-national-health-advocacy-leaders-gene-kestenbaum-ccfa/8124/Gene Kestebaum, past president for the Crohn's and Colitis Foundation, shares his story of child advocacy-turned-health leadership work.Reducing Child Obesity Nationwide: The Robert Wood Johnson Foundation Project
https://reachmd.com/programs/conversations-on-health-care/reducing-child-obesity-nationwide-robert-wood-johnson-foundation-project/7403/This week, hosts Mark Masselli and Margaret Flinter speak with Dr. John Lumpkin, Sr. VP and Director of Targeted Teams at the Robert Wood Johnson Foundation. Dr. Lumpkin runs the RWJF project targeting childhood obesity and talks about the myriad strategies aimed reducing the obesity epidemic amongMigraines and Beyond: Narcotic Therapy and Pain Control
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/migraines-and-beyond-narcotic-therapy-and-pain-control/4274/Many physicians today feel overburdened by the task of pain management. The current state of pain management stands in sharp contrast to years past, when our options were once relatively limited in the treatment of pain associated with headaches and other ailments. When is it appropriate to prescribAdvances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
https://reachmd.com/programs/project-oncology/advances-in-early-stage-breast-cancer-treatment-a-recap-of-the-natalee-trial/15695/How can the potential results of a phase III study help breast cancer patients? Find out.Expanding the Nation's Behavioral Health Work Force: Updates from SAMHSA
https://reachmd.com/programs/conversations-on-health-care/expanding-nations-behavioral-health-work-force-updates-samhsa/7875/This week, hosts Mark Masselli and Margaret Flinter speak with Kana Enomoto, Acting Administrator of the Substance Abuse and Mental Health Services Administration, the division of the HHS dedicated to mental health disorders and addiction. She talks about SAMHSA's initiatives aimed at improving acceTreat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
https://reachmd.com/programs/cme/treat-target-transform-applying-treat-to-target-principles-in-the-management-of-generalized-myasthenia-gravis-gmg/39980/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.